Angioscopic evaluation of site-specific administration of ReoPro.

@article{Bailey1997AngioscopicEO,
  title={Angioscopic evaluation of site-specific administration of ReoPro.},
  author={Stephen R Bailey and Edward O'Leary and Robert J. Chilton},
  journal={Catheterization and cardiovascular diagnosis},
  year={1997},
  volume={42 2},
  pages={181-4}
}
Systemic administration of newer antiplatelet agents such as the GP IIb/IIIa agent ReoPro (Centocor BV Leiden, The Netherlands) has been shown to decrease the early incidence of recurrent ischemia and recurrent myocardial infarction. The currently approved protocol for administration of ReoPro involves an initial weight adjusted bolus followed by a systemic infusion over the next 12 hr. The systemic administration is proposed as the only route of administration because it is stated that the… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…